Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia.

Address: Department of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy. [email protected].; Department of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy.; Department of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy.; School of Life Sciences, University of Nottingham, Nottingham, UK.; Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.; Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133, Rome, Italy.; Laboratory of Cell Engineering, Institute of Biotechnology; Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2020RU009, 20 Dongda Street, Beijing, 100071, China.; Institute of Nutrition and Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.; Institute of Nutrition and Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.; The Third Affiliated Hospital of Soochow University, Changzhou, China.; The Child Health Institute of New Jersey, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.; Institutes for Translational Medicine, Soochow University, Suzhou, China.; Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133, Rome, Italy. [email protected].; IRCCS Neuromed, Pozzilli, IS, Italy. [email protected].; Department of Pharmacology, School of Medicine, University of Nevada, Reno, NV, 89557, USA. [email protected].; Department of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy. [email protected].; DZNE German Center for Neurodegenerative Diseases, Bonn, Germany. [email protected].